Characteristics of the five eligible randomized trials in this meta-analysis.
收藏数据链接：
官方服务：
资源简介：
PS: Performance Status. Van: Vandetanib. Doc: Docetaxel. Pac: Paclitaxel. Car: Carboplatin. Pem: Pemetrexed. Gem: Gemcitabine. NR: NO Report.
创建时间：
2015-12-02
